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Appropriate fetal growth relies upon adequate placental nutrient transfer.
Birthweight:placental weight ratio (BW:PW ratio) is often used as a proxy for placental
efficiency, defined as the grams of fetus produced per gram placenta. An elevated
BW:PW ratio in an appropriately grown fetus (small placenta) is assumed to be due
to up-regulated placental nutrient transfer capacity i.e., a higher nutrient net flux per
gram placenta. In fetal growth restriction (FGR), where a fetus fails to achieve its
genetically pre-determined growth potential, placental weight and BW:PW ratio are
often reduced which may indicate a placenta that fails to adapt its nutrient transfer
capacity to compensate for its small size. This review considers the literature on BW:PW
ratio in both large cohort studies of normal pregnancies and those studies offering
insight into the relationship between BW:PW ratio and outcome measures including
stillbirth, FGR, and subsequent postnatal consequences. The core of this review is the
question of whether BW:PW ratio is truly indicative of altered placental efficiency, and
whether changes in BW:PW ratio reflect those placentas which adapt their nutrient
transfer according to their size. We consider this question using data from mice and
humans, focusing upon studies that have measured the activity of the well characterized
placental system A amino acid transporter, both in uncomplicated pregnancies and in
FGR. Evidence suggests that BW:PW ratio is reduced both in FGR and in pregnancies
resulting in a small for gestational age (SGA, birthweight <10th centile) infant but this
effect is more pronounced earlier in gestation (<28 weeks). In mice, there is a clear
association between increased BW:PW ratio and increased placental system A activity.
Additionally, there is good evidence in wild-type mice that small placentas upregulate
placental nutrient transfer to prevent fetal undergrowth. In humans, this association
between BW:PW ratio and placental system A activity is less clear and is worthy of
further consideration, both in terms of system A and other placental nutrient transfer
processes. This knowledge would help decide the value of measuring BW:PW ratio in
terms of determining the risk of poor health outcomes, both in the neonatal period and
long term.
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INTRODUCTION:
BIRTHWEIGHT:PLACENTAL WEIGHT
RATIO AND THE IMPORTANCE OF
ADEQUATE PLACENTAL NUTRIENT
TRANSFER TO THE FETUS
Appropriate nutrient provision to the fetus, via the placenta,
is essential for optimal fetal growth. Placental dysfunction,
and consequent reduced nutrient supply, is associated with
fetal growth restriction (FGR), a condition in which the fetus
fails to achieve its genetically pre-determined growth potential
(Mahendran et al., 1993; Glazier et al., 1997; Baschat et al., 2007).
The ability of the placenta to maintain adequate nutrient delivery
to the fetus is determined by a number of factors including
the total surface area of syncytiotrophoblast (transporting
epithelium) available for exchange, and the abundance and
activity of nutrient transporters [(Desforges and Sibley, 2010);
placental nutrient transporter activity and expression is reviewed
in detail elsewhere (Jones et al., 2007; Desforges and Sibley, 2010;
Dilworth and Sibley, 2013)].
There is substantial evidence from studies in animals
that the placenta regulates its nutrient transfer efficiency by
morphological and functional adaptations which result in
optimal fetal growth (Coan et al., 2008a; Fowden et al.,
2009; Sandovici et al., 2012). Placental efficiency is commonly
defined by birthweight:placental weight ratio (BW:PW ratio)
i.e., the grams of fetus produced per gram placenta (Wilson
and Ford, 2001). Placental efficiency thus acts as a proxy
measure of how placental development/function has adapted
to meet fetal nutritional requirements (Fowden et al., 2009).
The morphological or functional placental adaptations (i.e., in
nutrient transfer per gram placenta) can occur in response to
either maternal or fetal cues that ultimately result in a change in
placental efficiency (Fowden et al., 2009). It has been postulated
that adaptations take place in order to maintain appropriate fetal
growth, and that failure of placental adaptations may result in a
fetus that is either too small or large with respect to its genetic
growth potential (Sibley et al., 2010).
A pregnancy with a relatively large fetus, compared with the
average fetal weight of the population, will have had a higher
total net transfer of nutrients across the placenta over the course
of gestation than the pregnancy with a relatively smaller fetus.
An increase in placental efficiency, as evidenced by an increased
BW:PW ratio, implies that nutrient transfer per gram placenta
must have increased. Accordingly the reverse is true; a reduced
BW:PW ratio suggests that nutrient transfer, per gram placenta, is
reduced. Data from mouse studies suggest that this is indeed the
case. In a wild-type (WT) mouse litter of normally grown fetuses
near term, those fetuses with the lightest placentas within a litter
are of an equivalent size to those from the heaviest placentas;
accordingly the fetal:placental weight ratio (F:P ratio) is higher in
the lightest placentas (Coan et al., 2008a). Importantly, in these
lightest placentas within the WT litter, with an increased F:P
ratio and placental efficiency, placental nutrient transfer (glucose
and methylaminoisobutyric acid, a marker of system A amino
acid transport) per gram placenta, is indeed also increased (Coan
et al., 2008a). Thus, F:P ratio may be a useful predictor of those
placentas that have adapted their nutrient transfer (per gram
placenta). Additionally, it has been observed in a number of
rodent models of FGR that F:P ratio is reduced (Jansson et al.,
2006; Coan et al., 2008b, 2010; Kusinski et al., 2012), suggesting
an inefficient placenta that failed to adapt its nutrient supply
to meet the demands of the rapidly growing fetus and indeed,
placental amino acid transport is reduced in all of these models
(Aardema et al., 2001; Jansson et al., 2006; Coan et al., 2008b,
2010; Kusinski et al., 2012).
Less well understood is the association between placental
efficiency, defined as above, and nutrient transfer in humans.
Evidence showing that changes in BW:PW ratio were matched
with similar alterations in placental nutrient transfer may help
to identify those placentas adapting, or failing to adapt, their
placental nutrient transfer according to fetal demand. This
is important because, taking the example of FGR, a reduced
BW:PW ratio may be indicative of inadequate placental nutrient
transfer.
The review will consider two major themes. Firstly, in
reviewing studies in women, we focus mainly upon large
cohort studies measuring BW:PW ratio and offering insight
into its relationship with outcome measures including stillbirth,
abnormal fetal growth, and subsequent postnatal consequences.
Secondly, this review will consider, in humans and mice, whether
measures of placental nutrient transfer do in fact relate to
measures of BW:PW ratio. As part of this, published data from
our own in vitro studies of placental nutrient transfer in human
will be collated and compared with other reported data in both
the mouse and human, focusing on the extensively studied
system A amino acid transporter system. Our goal is to help
to ascertain whether BW:PW ratio is a fair proxy for placental
efficiency in terms of nutrient transfer in human pregnancy
and whether large deviations in BW:PW ratio, and particularly
a reduced BW:PW ratio, may indicate those pregnancies with
a failing placenta. It is these pregnancies that would likely
benefit most from extra antenatal surveillance and therapeutic
intervention in the future, particularly in the prevention of
stillbirth (Heazell et al., 2015).
FACTORS THAT INFLUENCE BW:PW
RATIO AND CONSEQUENCES OF AN
ALTERED BW:PW RATIO FOR FETAL
WELLBEING
Published BW:PW ratio measures are influenced by whether the
placenta was weighed untrimmed or trimmed (removal of fetal
cord and membranes) and this information is provided in the
studies presented below. It is not intended for this review to be
a systematic analysis of all studies quoting BW:PW ratio. Rather,
the major focus is upon larger cohort studies that have examined
important variables that may affect BW:PW ratio including
sex, parity, ethnicity, and gestational age. Some studies present
PW:BW ratio rather than BW:PW ratio but for consistency,
all analysis and discussion of these studies has been related to
BW:PW ratio.
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There has been considerable interest in BW:PW ratio since
the work of Barker and colleagues who suggested that those
pregnancies with relatively large placentas relative to birthweight
(low BW:PW ratio) are at increased risk of hypertension in
adulthood (Barker et al., 1990). Similar findings have since been
demonstrated in children; a low BW:PW ratio was associated
with an increased risk of raised blood pressure (above 90th
centile of blood pressures recorded in over 29,000 children) at
7-years of age (Hemachandra et al., 2006). Additionally, being
in the lowest tertile of BW:PW ratio increases the relative
risk of cardiovascular disease, and stroke in particular, in
adulthood (Risnes et al., 2009). This leads to the suggestion that
inefficient placentas, with supposed inadequate nutrient transfer,
may be important in this programming of the fetus in utero,
ultimately leading to increased risk of cardiovascular disease into
adulthood.
BW:PW ratio increases across gestation as placental growth
slows and fetal growth accelerates during the third trimester
(Molteni et al., 1978). BW:PW ratio doubles from week 24
of pregnancy to term (38–40 weeks; Almog et al., 2011;
Wallace et al., 2013). A number of large cohort studies have
determined BW:PW ratio in pregnancies with normal outcome
(Burkhardt et al., 2006; Almog et al., 2011; Wallace et al.,
2013) and birthweight is 5–7 times greater than placental weight
at term. In a comprehensive study based in Aberdeen, UK,
Wallace et al. constructed placental weight (untrimmed) and
BW:PW ratio centiles for over 89,000 pregnancies (Wallace
et al., 2013). Separate centile charts were produced according
to parity and fetal sex and split to account for gestational age
(from 24 to 43 weeks). Placental weight and BW:PW ratio
centiles were presented and showed that BW:PW ratio was
higher in males but parity had no effect. This is in contrast to
placental weight; multiparous women had significantly heavier
placentas than nulliparous women. Additionally, the placentas
of males were significantly heavier than those of females
but this effect of sex was less marked than the effect of
parity.
This splitting of BW:PW ratio by sex has also been
documented in another large cohort study in Montreal, Canada
(Almog et al., 2011) which calculated centiles similar to those in
the study by Wallace et al.; the effects of parity were not reported
in this study but centiles for placental weights (trimmed) were
also produced for twin pregnancies. This study did not compare
BW:PW ratio between males and females statistically but did
show that the median placental weight at term was higher for
males (679 g) than for females (668 g). Additionally, there was
a correlation between gestational age and BW:PW ratio in both
females and males. The authors concluded that these data should
act as a reference tool for North American populations, but urged
caution if used to compare against other cohorts, particularly
when considering the different ethnicities that may be present
within these different populations.
One of the largest studies quoting BW:PW ratio (untrimmed
placental weight) examined over 500,000 singleton births in
Norway (Haavaldsen et al., 2013); this encompassed all births
between 1999 and 2008 and included confounders such as pre-
eclampsia, diabetes, and those pregnancies conceived following
assisted reproductive technology. This study considered the
relative risk of fetal death in the lowest and highest quartiles
of BW:PW ratio in both pre-term (23–36 weeks) and term
(37–42 weeks) pregnancies. Values were adjusted for maternal
characteristics including age, parity and smoking status and
the other confounders detailed above. The study demonstrated
elevated odds ratios (OR) for fetal death in both the lowest (OR
1.79, 95%CI 1.55–2.08) and highest (1.67, 1.44–1.94) BW:PW
ratio quartiles in the pre-term group; in the term group, only
the highest BW:PW ratio centile demonstrated an increased OR
(1.76, 1.50–2.06) compared to the middle centiles. This suggests
that, in this Norwegian population, a smaller placenta relative to
fetal size, hypothesized to be a more efficient placenta in terms of
nutrient transfer, was a risk factor for fetal death at term.
Williams and colleagues assessed BW:PW ratio in over 2500
pregnancies in Perth, Australia, and showed that both placental
weight (untrimmed) and birthweight were better independent
predictors of newborn morphometrics (such as abdominal and
head circumference, ponderal index) than BW:PW ratio and thus
concluded that BW:PW ratio was a poor proxy of fetal growth
(Williams et al., 1997). This emphasizes a seemingly obvious, but
important point, that in order to fully understand the significance
of BW:PW ratio in relation to placental efficiency, it is essential to
consider it in the context of the actual birthweight and placental
weight (or birthweight/placental weight centile), since a normal
BW:PW ratio could be the result of a birthweight and placental
weight that are both normal, both high, or both low (Williams
et al., 1997; Hutcheon et al., 2012). The authors also commented
on the importance of accurate gestational ages when considering
BW:PW ratio (Williams et al., 1997).
Shehata and colleagues studied 19,000 women in Canada
delivering infants appropriate for gestational age (AGA) at
term, grouped into centiles of BW:PW ratio. They demonstrated
that a BW:PW ratio below the 10th centile presented with a
greater risk of both NICU admission (OR 2.54, 2.01–3.20) and
an apgar score below 7 (OR 1.82, 1.21–2.73) whilst a high
(above 90th centile) BW:PW ratio appeared to reduce the risk
of NICU admission (OR 0.59, 0.38–0.90; Shehata et al., 2011).
This confirmed a study by Lao and Wong demonstrating again
in AGA only, that infants with a low BW:PW ratio (greater
than 1 SD below the mean of the population, untrimmed
placentas) presented with an increased risk of a low apgar score
(<7; Lao and Wong, 2001). These data suggest that, even in
a seemingly lower risk AGA population, BW:PW ratio may be
indicative of immediate and longer term health risks for an
individual.
Individually, a number of these studies act as a useful reference
tool for comparisons of BW:PW ratio against populations
with similar characteristics (e.g., ethnicity). Collectively they
demonstrate some of the factors that influence BW:PW ratio
including gestational age, ethnicity, parity, and fetal sex,
and begin to outline the links between an altered BW:PW
ratio and risk of short and long-term health. The next
section discusses the concept of placental adaptation and
considers whether BW:PW ratio can be used to indicate those
placentas that adapt nutrient transfer in relation to placental
size.
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EVIDENCE OF PLACENTAL ADAPTATION
IN NORMAL PREGNANCY
It is well established that there is a positive correlation between
placental weight and birthweight in human pregnancy (Winick
et al., 1967; Crawford et al., 1987; Thame et al., 2001, 2004; see
also Figure 1). This suggests that the size of the placenta dictates
the size of the fetus, an assumption supported experimentally by
studies in animals; it was shown over 30 years ago that sheep
in which placental size was reduced by removal of endometrial
caruncles had growth restricted lambs (Robinson et al., 1979;
Harding et al., 1985). The correlation between placental weight
and birthweight suggests that BW:PW ratio should be fairly
constant between different women. Thus, large deviations in
BW:PW ratio from the norm are indicative of either a baby
that is relatively larger, or smaller, than would be expected from
a placenta of a certain size, or conversely, a placenta that is
relatively larger, or smaller than would be expected from a baby of
a certain size. This may indicate those placentas that are adapting
their nutrient supply to compensate for a relatively small or large
placental size.
Placental adaptation has been the subject of previous reviews
(Fowden et al., 2009; Sibley et al., 2010; Sandovici et al., 2012)
and the concept is summarized here. In normal pregnancy, the
growth of the fetus is by definition, within the normal range of
fetal weights and net placental nutrient transfer over the course
of gestation is sufficient to meet fetal nutrient requirements.
This, however, is unlikely to tell the whole story and there may
have been specific points during normal pregnancy where net
placental nutrient transfer was insufficient to meet fetal nutrient
demand. This scenario would lead to either undergrowth or
overgrowth of the fetus unless the placenta was able to adapt
its nutrient transfer relative to fetal demand. A placenta could
FIGURE 1 | Trimmed placental weight vs. birthweight in an appropriate
for gestational age (>10th, <90th centile of IBCs) population. There was
a significant correlation between placental weight and birthweight (P < 0.0001,
Spearman correlation). N = 210. Data represents a collation of our previously
published data (Ditchfield et al., 2010, 2015; Hayward et al., 2012, 2013;
Brereton et al., 2013; Coleman et al., 2013; Lean et al., 2014; Jones et al.,
2015; Mills et al., 2015) and represents a well characterized cohort all of whom
delivered at St Mary’s Hospital, Manchester.
adapt by increasing, or decreasing, the transfer of nutrients per
gram. This may be through a combination of morphological
and functional adaptations. It has been suggested that the ability
of the placenta to adapt according to fetal nutrient demand
prevents FGR or fetal macrosomia occurring more frequently
(Sibley et al., 2010). By contrast, in cases of abnormal fetal growth,
it is hypothesized that the placenta fails to adapt its nutrient
transfer according to fetal nutrient demand, thus resulting in a
fetus that is either too small or large.
Some of the strongest evidence for placental adaptation and
of a direct link between changes in BW:PW ratio comes from a
study by Coan and colleagues in the mouse (Coan et al., 2008a),
which we touched on in the introduction to this review. In this
study, F:P ratio was assessed in WT mice at both embryonic day
(E) 16 and E19 (term = E20). As in humans, F:P ratio increases
across gestation but this difference is even more pronounced
in mice; F:P ratio rises from around 4 at E16 to ∼11–14 at
E19. This reflects the rapid fetal growth rate, the stagnation of
placental growth and the increased rates of nutrient transfer
seen across these time points (Coan et al., 2008a; Dilworth
et al., 2011). In the study by Coan et al., natural variations in
placental size were investigated by examining the lightest vs.
heaviest placenta within a WT litter and assessing fetal weight
and F:P ratio from these individuals. The authors reported a
reduction in placental weight of around 30% between lightest
and heaviest placentas at both gestational ages. However, fetal
weight was significantly lower in fetuses from the lightest vs.
heaviest placentas at E16; by E19, the day before term, this
difference was no longer apparent (Coan et al., 2008a). To explore
the placental mechanisms underpinning this “normalization”
of fetal weight between E16 and E19, the authors examined
whether there were any morphological or functional changes
in the lightest vs. heaviest placentas between these time-points.
Independent of whether it was the lightest or heaviest placenta
within the litter, there was a significant increase in mean
surface area of the maternal and fetal-facing surfaces of the
interhaemal trophoblast membrane between E16 and E19 with
an accompanying reduction inmean thickness of this membrane.
Together, these resulted in a significant increase in the theoretical
diffusion capacity at E19. When examining the different zones
of the mouse placenta, it was also observed that the % volume
fraction of the labyrinthine zone (exchange layer of the mouse
placenta) was relatively increased at E19 vs. E16. These changes
represent normal morphological changes that occur in the mouse
placenta as pregnancy progresses. When comparing lightest vs.
heaviest placentas, there were no differences in mean surface
area or thickness of the interhaemal trophoblast membrane at
E16 or E19; thus the theoretical diffusion capacity was unaltered.
Lightest placentas demonstrated a reduced size of junctional zone
(suggested to play an important endocrine role) and decidual
basalis layer at E16 with no difference in the size of the
labyrinthine zone. At E19, the reverse was true; the labyrinthine
zone was reduced in the lightest vs. heaviest placentas with
no change in the junctional zone or decidual basalis. When
expressed as % of the total placental size, the only differences
observed were a reduced labyrinthine and junctional zone at
E16 in the lightest vs. heaviest placentas, indicating that these
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reductions were more than simply a proportional reduction
appropriate to the reduced placental size.
To examine the evidence for functional adaptation within
these placentas, Coan and colleagues assessed placental nutrient
transfer between E16 and E19, focusing upon markers of passive
permeability (14C-inulin), facilitated diffusion (14C-glucose), and
secondary active transport (14C-MeAIB). MeAIB is a non-
metabolizable substrate used as a proxy for the system A amino
acid transporter. These studies were carried out in vivo following
injection of radiolabeled tracers into the maternal circulation
and subsequent fetal radiolabel counts, allowing calculation
of unidirectional maternofetal clearance (Kmf). The authors
found no difference in Kmf (per g placental tissue) of
14C-
inulin or glucose between lightest and heaviest placentas at E16
but Kmf of
14C-MeAIB was significantly upregulated in the
lightest placentas. At E19, Kmf of
14C- glucose and MeAIB were
significantly increased in lightest vs. heaviest placentas whilst
14C−inulin demonstrated no difference. The authors concluded
that there were morphological and functional changes within
the placenta in response to changes in placental size and that
these changes, hypothesized to be adaptations, may occur in
response to fetal nutrient demand. These changes were largely
morphological at E16 and functional at E19 and also suggest that
large and small placentas adopt different strategies to maintain
appropriate fetal growth. A study comparing lightest and heaviest
placentas with those around mean weight within the same litter
would help to corroborate this further.
These data provide evidence of placental adaptation, in terms
of specific facets of nutrient transfer capacity, in normal mouse
pregnancy. Studies specifically investigating this in human are
largely limited to placental system A amino acid transporter
activity, and will be discussed later in this review. Firstly, it
is important to comment on the studies that have investigated
BW:PW ratio in complications of pregnancy.
BIRTH WEIGHT:PLACENTAL WEIGHT
RATIO AND PLACENTAL ADAPTATION IN
COMPLICATIONS OF PREGNANCY
A significant reduction in BW:PW ratio may be indicative of
placental dysfunction, the major cause of FGR, and a number
of studies report reduced BW:PW ratio in FGR and SGA
populations (Bortolus et al., 1998; Lurie et al., 1999; Lackman
et al., 2001; Macdonald et al., 2014a,b). Molteni and colleagues
charted gestational changes in placental and fetal weight infants
destined to be SGA (BW < 10th centile), AGA (BW > 10th,
<90th centile) or large for gestational age (LGA, BW > 90th
centile) and showed that placentas of SGA babies do not gain
weight after 36 weeks gestation whereas placental weight in AGA
and LGA babies continues to rise until 42 weeks (Molteni et al.,
1978). In a comprehensive study of birthweight and untrimmed
placental weight in over 40,000 pregnancies, Macdonald and
colleagues found that SGA infants had lower BW:PW ratio
compared to AGA infants earlier in pregnancy (24–28 weeks)
but that this difference was not as great at term, with a small
reduction in BW:PW ratio in females only (Macdonald et al.,
2014a). The finding that the differences in BW:PW ratio between
SGA, AGA, and LGA groups is more marked earlier in gestation
has been observed previously (Molteni et al., 1978; Imada et al.,
2012). The decreased BW:PW ratio earlier in gestation in the
SGA group (Macdonald et al., 2014a) would be indicative of
a fetus that is undergrown relative to placental size and thus
implies functional inefficiency of the placenta, which may imply
a pathological process.
Macdonald et al. suggested that BW:PW ratio may be a
candidate to aid detection of SGA fetuses early in pregnancy;
this would be particularly attractive in terms of identifying those
pregnancies complicated by FGR, but would rely on accurate
estimation of fetal and placental size following ultrasonography.
The authors also suggest that this decreased BW:PW ratio
in the SGA group early in gestation, when compared with
the placental weight and birthweight centiles across gestation,
is likely due to altered placental function rather than size,
which again hints toward a pathological process (Macdonald
et al., 2014a). Following this study, the authors investigated
the links between obstetric conditions associated with hypoxia
and BW:PW ratio (using untrimmed placental weight data),
separating their data into three groups (<33 weeks gestation,
33–37 weeks and >37 weeks) given the effect of gestation on
BW:PW ratio (Macdonald et al., 2014b). The authors found
that obstetric conditions associated with fetal hypoxia, both due
to pre-placental hypoxia (e.g., maternal anemia, smoking) or
placental hypoxia [e.g., preeclampsia (PE), SGA, placenta previa]
were more likely to be associated with a BW:PW ratio below the
10th centile (Macdonald et al., 2014b) with a higher likelihood of
a reduced BW:PW ratio in PE before 33 weeks and SGA at term.
Maternal anemia has been previously linked with low BW:PW
ratio (Godfrey et al., 1991).
Lackman et al. demonstrated that babies below the 3rd
centile of birthweights, classed as FGR in this study, had a
significantly reduced BW:PW ratio, based upon untrimmed
placental weights, compared with AGA pregnancies near term.
This significant reduction was also seen in babies between
the 3rd and 10th birthweight centiles, which was referred to
as “borderline FGR” in this study (Lackman et al., 2001). A
study in Israel by Lurie et al. demonstrated that babies born
at term below 2.5 kg demonstrated the lowest BW:PW ratio
(untrimmed placental weight) although this was based upon
birthweight rather than individualized birthweight centiles as
used in most other studies. This study also reinforced the
importance of gestational age upon BW:PW ratio and showed
that even at term (37–42 weeks) there were subtle changes in
BW:PW ratio week on week, which complicates analyses between
individuals (Lurie et al., 1999). In a Finnish cohort of over 16,000
women, pregnancies with a SGA infant (below 10th birthweight
centile) had a small, but statistically significantly reduced
BW:PW ratio compared with AGA (untrimmed placental
weights) and taking into account gestational age (Heinonen
et al., 2001). When comparing AGA with SGA individuals
that were matched for birthweight, it was the SGA group
that demonstrated an increased BW:PW ratio, at odds to
many other studies but in support of the study by Heinonen
and colleagues that showed a small, but significantly elevated
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BW:PW ratio in SGA vs. AGA infants (Heinonen et al.,
2001).
Lao and colleagues examined BW:PW ratio in 470 pregnancies
in Hong Kong and compared AGA, SGA, and LGA groups.
They showed that BW:PW ratio was significantly lower in
the SGA group compared with AGA with a trend toward an
increased BW:PW ratio in the LGA group (Lao andWong, 1996).
Placental (untrimmed) weight in the SGA group however was
not significantly different from the AGA group, indicating that
this reduction in BW:PW ratio was primarily due to the reduced
birthweight in the SGA group; the authors suggested that this
may be due to limitations on fetal growth in order to maintain
placental function as has been previously suggested (Barker et al.,
1993). To examine this SGA group in further detail, the same
authors carried out a retrospective study examining 252 cases of
SGA only. These cases were split into three groups according to
their BW:PW ratio, greater than 1SD above (high) or below (low)
the mean BW:PW ratio, or within 1 SD of the mean (normal)
(Lao andWong, 1999). It was demonstrated that BW:PW ratio in
the low group was reduced due to both a larger placenta (weighed
untrimmed) and reduced birthweight compared with the normal
group. These differences were independent of any alterations
in maternal characteristics with the exception of a trend (not
significant) toward increased smoking within the low group.
Due to the increased neonatal morbidity in this sub-group, the
authors suggested that this SGA group with a low BW:PW ratio
may be more indicative of FGR. These findings indicate the
importance of trying to classify individual sub-groups within an
SGA cohort.
Manipulation of both fetal and placental growth in mice, for
example by the production of genetic knock out or transgenic
mice, results in alterations in F:P ratio. Mice with deletion of the
endothelial nitric oxide synthase (eNOS−/−) gene have reduced
uterine blood flow velocity and reduced fetal weight with no
difference in placental weight; thus F:P ratio is reduced in this
model of FGR (Kulandavelu et al., 2012; Kusinski et al., 2012).
Manipulation of the insulin-like growth factor 2 (Igf2) axis in
mice also results in altered fetal growth. Mice with global deletion
of Igf2 have severely reduced fetal and placental weight and a
reduced F:P ratio near term (Constância et al., 2005). In this
model, nutrient delivery to the fetus (glucose and MeAIB) is
reduced. It has been suggested that these mice do not adapt
their placental nutrient transfer according to reduced placental
size and thus FGR ensues. However, in placental specific Igf2
knockout (P0) mice, in which fetal levels of Igf2 are unaffected,
there is evidence both of placental adaptation and of its failure
(Constância et al., 2002, 2005). At embryonic day (E) 16, 4
days prior to term, there is reduced placental weight in P0 pups
(30% smaller than WT) with fetal growth only reduced by 4%
compared with WT. By E19, FGR (25% reduction in fetal weight
vs. WT) has ensued with placental weight remaining reduced
in P0 compared with WT siblings. This led to the hypothesis
that there were functional adaptations within the smaller P0
placenta occurring at E16 which prevented fetal undergrowth,
and that failure of this adaptation resulted in FGR at E19. To
test this hypothesis, placental nutrient transfer (51Cr-EDTA, a
marker of passive permeability, and 14C-MeAIB) was assessed
in a similar manner to the study on WT mice by Coan and
colleagues and described above (Coan et al., 2008a). It was
demonstrated that placental transfer of MeAIB, per gram of
placenta, was upregulated at E16; by E19 this upregulation no
longer occurred and delivery of MeAIB, as measured in the P0
fetus, was reduced vs. WT (Constância et al., 2002). Placental
transfer of 51Cr-EDTA was comparable between P0 and WT
at E16, but reduced in P0 at E19 (Constância et al., 2002), an
observation confirmed in a separate study and also demonstrated
for 14C-mannitol, another marker of passive permeability (Sibley
et al., 2004). Interestingly, placental transfer of 14C-glucose,
per gram of placenta, was comparable between P0 and WT
at both E16 and E19 (Constância et al., 2005). Despite this
observed FGR, F:P ratio in P0 knockout mice remains higher at
E19; indeed activity of some nutrient transport systems such as
glucose and calcium still appear to be increased at E19 in the
placentas of these mice (Constância et al., 2005; Dilworth et al.,
2010). This upregulation in calcium transport in P0 placentas
supports data in humans that plasmamembrane calciumATPase,
located on the fetal facing basal plasma membrane of the
syncytiotrophoblast and responsible for transporting Ca2+ to the
fetus against a concentration gradient, is upregulated in human
FGR (Strid et al., 2003). This remains the only placental nutrient
transporter, thus far, to be shown to be upregulated in human
FGR and provides evidence to suggest that, for some nutrient
transport systems, adaptations in placental nutrient transfer may
also be present in cases of abnormal fetal growth.
Placental adaptation in relation to overgrowth has also been
studied in mice. Increasing levels of fetal and placental IGF2,
by deleting the H19 region that incorporates the H19/Igf2
imprinting control region, resulted in placental and fetal
overgrowth (Angiolini et al., 2011). Despite this fetal overgrowth,
F:P ratio was reduced in H19 knockout mice at both E16 and
E19. This was accompanied by reductions in placental nutrient
transfer capacity; markers of passive permeability, glucose and
system A amino acid transport were all reduced per gram
placenta, and hints toward mechanisms to limit the extent of
the fetal overgrowth; i.e., further evidence of a placenta that is
demonstrating adaptation. These data in mice provide strong
evidence of placental adaptation in relation to size, and to F:P
ratio, in both FGR and fetal overgrowth.
BW:PW ratio has been measured in other complications of
pregnancy in humans, including gestational diabetes mellitus
(GDM) and pre-eclampsia (PE). Lao and colleagues performed
a retrospective study on women with GDM or impaired glucose
tolerance (IGT), both of which were controlled through diet (Lao
et al., 1997). These women were compared with women with
similar risk factors for GDM/IGT, but who demonstrated normal
glucose tolerance. BW:PW ratio (untrimmed placental weights)
was decreased in both GDM and IGT groups compared with
controls, but this may have been confounded by differences in
gestational ages between groups. In a study in Korea, Kim and
colleagues suggested that BW:PW ratio was increased in GDM
although numbers were low (33 GDM v 82 controls; Kim et al.,
2014). In this same study, the authors also demonstrated that
BW:PW ratio was reduced in PE vs. controls; the effect was seen
independent of whether PE presented with or without FGR (Kim
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et al., 2014) and was complicated by the fact that the PE group
tended to deliver around 3 weeks earlier on average.
Taken together, these studies suggest that there are deviations
in BW:PW ratio when comparing complicated pregnancies with
normal outcomes. In particular, the weight of evidence suggests
that BW:PW ratio is reduced in both SGA and FGR, with the
caveat that this is more profound earlier in gestation. To assess
whether changes in BW:PW ratio, and thus placental efficiency,
are mirrored by changes in placental nutrient transfer capacity in
human pregnancy, as seen in the mouse, the following section
considers associations between the activity of the placental
system A amino acid transporter system and BW:PW ratio.
SYSTEM A AMINO ACID TRANSPORTER
ACTIVITY IN RELATION TO BW:PW;
MICROVILLOUS PLASMA MEMBRANE
VESICLE STUDIES
SystemA is a transporter system present on both themicrovillous
and basal plasma membranes of the syncytiotrophoblast of the
placenta that transports small, neutral amino acids, such as
alanine, serine, and glycine, in a sodium dependent manner
(Mahendran et al., 1993; Glazier et al., 1997). System A consists
of three isoforms within the placenta. These isoforms are the
Na+-coupled neutral amino acid transporters (SNATS) 1, 2, and
4, encoded by SLC38A1, 2 and 4, respectively (Mackenzie and
Erickson, 2004; Desforges et al., 2006). Both because of the
important contribution the substrates of this transporter make
to fetal growth and because its placental activity is relatively
straightforward to measure, a number of studies have related
placental system A activity to fetal and placental growth. In
SGA and FGR infants, reduced placental size is frequently
observed and system A activity (permg placental protein) also
has been shown to be reduced compared with AGA populations,
particularly in pre-term groups with severe FGR (Mahendran
et al., 1993; Glazier et al., 1997; Harrington et al., 1999; Jansson
et al., 2002a; Shibata et al., 2008). Likewise, data in mice and
rats suggest that placental system A amino acid transport is
dysregulated in genetic and dietary models of FGR (Malandro
et al., 1996; Constância et al., 2002; Jansson et al., 2006; Kusinski
et al., 2012; Stanley et al., 2012). These studies appear to indicate
the importance of placental system A transport in terms of fetal
growth. Placental system A activity has also been measured in
a number of studies investigating uncomplicated pregnancies
and these studies afford the opportunity to examine whether
system A activity is normally associated with altered BW:PW
ratio, and thus placental efficiency, as demonstrated in the mouse
(Constância et al., 2005; Coan et al., 2008a; Dilworth et al., 2010,
2011).
Godfrey et al. (1998) investigated the activity of the system
A transporter in the syncytiotrophoblast microvillous plasma
membrane (MVM) in relation to birthweight in uncomplicated
pregnancy. System A activity was estimated by determining
the sodium-dependent component of 14C-MeAIB uptake into
MVM vesicles (relatively pure spheres of plasma membrane
with no intracellular machinery) (Glazier and Sibley, 2006)
isolated from these placentas. MeAIB, a non-metabolizable
substrate, is used as a proxy for system A activity. Whilst
there are sodium-independent mechanisms of MeAIB uptake,
not attributable to system A, the sodium-dependent component
of 14C-MeAIB uptake is a measure of system A activity. The
authors observed that system A activity (nmol/mg membrane
protein) was increased in the placentas of the smallest babies
(Godfrey et al., 1998), which was somewhat surprising given the
data showing that placental system A activity, permg protein,
is reduced in FGR and SGA (Mahendran et al., 1993; Glazier
et al., 1996, 1997; Shibata et al., 2008). This increased system A
activity was suggested to be a compensatory mechanism by the
placentas of these smaller infants within the normal birthweight
range in response to increased fetal nutrient demand. This is
of course akin to what was found in mice some years later: as
discussed in detail above, Kmf of
14C-MeAIB was upregulated
in the lightest vs. heaviest placentas of WT mice both at a time
point when fetal growth was reduced (E16) and normalized (E19)
(Coan et al., 2008a). Kmf of
14C-MeAIB was also upregulated in
the pathologically small Igf2 P0 knockout mouse placenta 4 days
prior to term at a time when fetal growth was reduced (but only
by 4%), vs. wild-type (Constância et al., 2002).
In the study by Godfrey et al. (1998), the relationship between
system A activity and BW:PW ratio was not reported. However,
in a separate study by Harrington et al., also employing the
MVM vesicle technique, a negative correlation was observed
between placental ratio (PW:BW ratio) and system A activity in a
well defined AGA population, which infers a positive correlation
between BW:PW ratio and system A activity (Harrington et al.,
1999). This is consistent with data in WT mice in vivo showing
that increased F:P is associated with increased unidirectional
maternofetal clearance of MeAIB per gram placenta (Coan et al.,
2008a). Together, this study of system A activity in MVM
vesicles from human placenta and studies of placental MeAIB
transfer by system A in the mouse are consistent in showing
a positive relationship with BW:PW ratio (F:P ratio in mice)
and thus placental efficiency. In the study by Harrington and
colleagues, there was no correlation between system A activity
and birthweight (Harrington et al., 1999), which is at odds
with the negative association suggested by Godfrey et al. (1998).
Whilst both of these studies employedMVMvesicles, Harrington
et al. investigated a defined AGA population (10th–90th centiles
based upon individualized birthweight centiles, IBCs, which take
into account maternal characteristics such as BMI, ethnicity and
parity, and gestational age) whereas Godfrey et al. defined normal
by birthweight alone and did not employ IBCs. In a study in
Sweden, Jansson and colleagues found a positive correlation
between system A activity in MVM vesicles (pmol/mg protein)
and birthweight (Jansson et al., 2013). The Jansson study included
data from women with a normal body mass index (BMI) and
fromwomen presenting with obesity (BMI> 30). Despite the fact
that there was no effect of maternal BMI on system A activity, the
presence of women with obesity in this dataset means caution is
required whenmaking comparisons with the data of Godfrey and
Harrington. The reasons for the reports of negative (Godfrey),
no relationship (Harrington) and positive associations (Jansson)
between MVM system A activity and BW are not obvious, and
Frontiers in Physiology | www.frontiersin.org 7 February 2016 | Volume 7 | Article 28
Hayward et al. Placental Adaptation and BW:PW
this along with the paucity of data relating system A activity
to BW:PW ratio in human pregnancy led us to examine these
associations further using data from our laboratory, as discussed
in the section that follows.
SYSTEM A AMINO ACID TRANSPORTER
ACTIVITY IN RELATION TO BW:PW;
PLACENTAL FRAGMENT STUDIES IN
MANCHESTER
Since we have performed a number of recent studies investigating
system A activity in placental villous fragments (Ditchfield
et al., 2010; Hayward et al., 2012; Lean et al., 2014), we
took the opportunity to collate this data and re-examine the
relationship between system A activity, BW, PW, and BW:PW
ratio in pregnancies resulting in AGA birth. All placental
tissue was acquired from women attending St Mary’s Hospital,
Manchester for their antenatal care and following informed
consent, under ethical approval by the NorthWest Haydock Park
Research Ethics Committee (08/H1010/05) and the University
of Manchester Ethics Committee. Procedures were followed in
accordance with institutional guidelines and conformed to the
standards set by the latest revision of the Declaration of Helsinki.
Placental villous fragments represent a different preparation
to the studies considered above which employed MVM vesicles
(Godfrey et al., 1998; Jansson et al., 2013) and the preparation
has been described in detail elsewhere (Greenwood and Sibley,
2006). Unlike MVM vesicles, villous fragments retain cellular
machinery. Fragments were incubated for set time periods in
14C-MeAIB and radiolabel accumulation (uptake) was measured
in relation to the protein content of the villous tissue. A
time-course was adopted over which MeAIB uptake into the
fragments was linear (typically 30–120min incubation with
MeAIB) to ensure that system A activity was assessed at initial
rate (Greenwood and Sibley, 2006). During their dissection
from the placenta, villous fragments are subject to damage
that could allow non-specific (i.e., not via system A) diffusion
of 14C-MeAIB into the tissue. To account for this, utilizing
the sodium-dependent nature of system A transport, uptake
of 14C-MeAIB into villous fragments was carried out both in
the presence and absence of sodium, enabling estimation of
system A activity as the sodium-dependent component of total
uptake. In the fragment preparation, sodium-dependent 14C-
MeAIB uptake was assumed to represent system A activity in
the MVM of the syncytiotrophoblast (Greenwood and Sibley,
2006).
Prior to carrying out this systemA re-analysis, we also took the
opportunity to examine a correlation between birthweight and
placental weight from those pregnancies for which we had system
A activity data (N = 60; Ditchfield et al., 2010; Hayward et al.,
2012; Lean et al., 2014). These data were combined with those
from other placentas of AGA pregnancies for which we have
previously published trimmed placental weight and birthweight
data (total N = 210; Brereton et al., 2013; Coleman et al., 2013;
Hayward et al., 2013; Ditchfield et al., 2015; Jones et al., 2015;
Mills et al., 2015). All of these pregnancies were classed as normal,
with fetal weights between the 10th and 90th centile of IBCs.
Additionally, pregnancies with confounders such as PE and BMI
over 30 were excluded. In common with previous population
studies (Thame et al., 2001, 2004), we demonstrated a significant
positive correlation between placental weight and birthweight
(Figure 1). Frequency (%) distribution curves for birthweight,
placental weight, and BW:PW ratio from this population are
shown in Figure 2 and afford the opportunity to relate system A
activity to our own population centiles for birthweight, placental
weight, and BW:PW ratio, as well as acting as a useful reference
for future comparative studies.
Within this population, system A activity was previously
measured using placental villous fragments (Ditchfield et al.,
2010; Hayward et al., 2012; Lean et al., 2014) on 60 placentas
and was re-plotted as a frequency (%) distribution, shown in
Figure 2D. These studies are a collective of a number of studies
in our laboratory (Ditchfield et al., 2010; Hayward et al., 2012;
Lean et al., 2014), all of which assessed systemA activity using the
same methodology as described above and in (Greenwood and
Sibley, 2006). As mentioned, a number of confounders suggested
to affect placental system A activity in women, such as obesity
(Jansson et al., 2013), GDM (Jansson et al., 2002b) “young”
(teenage; Hayward et al., 2012), and advanced (>40 years of age)
(Lean et al., 2014) maternal age were excluded and thus these 60
individuals represent a well defined “normal” cohort. All studies
assessed uptake across a range of time points and in all cases
14C-MeAIB uptake was linear up to 30min and this time point
was selected to relate system A activity to birthweight, placental
weight and BW:PW ratio.
System A activity permg of protein showed a significant
positive correlation with placental weight (P < 0.05, Figure 3A).
However, this correlation was not significant when placentas
below the 10th and above the 90th centile (but still within
the normal weight range) for placental weight were excluded
(P = 0.49). This suggests that, even in an AGA population,
it is placentas at the lower and upper ends of their weight
range that are resulting in the extremes of system A activity.
There was no correlation between birthweight and system A
activity permg protein (Figure 3B). When system A activity
permg protein was multiplied up to account for total placental
weight, this was positively correlated with birthweight (P <
0.01) consistent with the important role of system A in
supporting fetal growth. The lack of correlation between
system A activity permg protein and birthweight supports the
data of Harrington and colleagues who measured system A
activity in MVM vesicle preparations (Harrington et al., 1999).
However, it is at odds with the data by Godfrey and colleagues
who reported an inverse relationship between birthweight and
system A activity measured in MVM vesicles, and of Jansson
who reported a positive relationship. The reasons for these
disparities are currently unclear but may reflect, in part,
the differing techniques used to measure system A activity.
This is particularly important when considering that villous
fragments retain intracellular machinery whilst MVM vesicle
preparations assess uptake across a relatively pure MVM free
of the complications of placental metabolism. Also, this does
not explain the disparity between the Harrington and Godfrey
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FIGURE 2 | Frequency (%) distributions for trimmed placental weight (A), birthweight (B), BW:PW ratio (C), and placental system A activity (D) in an
AGA population following collation of previously published data (Ditchfield et al., 2010, 2015; Hayward et al., 2012, 2013; Brereton et al., 2013; Coleman
et al., 2013; Lean et al., 2014; Jones et al., 2015; Mills et al., 2015). Dotted lines denote the 10th, 50th, and 90th centile. Actual values are as follows (10th, 50th,
90th centile); For (A) 408, 520, and 642 g; (B) 2964, 3430, and 3896 g; (C) 5.2, 6.6, 7.5; (D) 33.2, 74.4, 115.6 pmol/mg protein. R2-values of best fit to Gaussian
distribution were as follows (A) 0.989, (B) 0.903, (C) 0.990, (D) 0.893. N = 210 for (A–C) and N = 60 for (D).
studies (Godfrey et al., 1998; Harrington et al., 1999) which
both employed MVM vesicles to measure system A activity.
These studies did, however, have differences in the way that
“normal” birthweight was defined; Godfrey et al. relied upon
actual birthweight and organized data into weight bins for
comparison, whereas Harrington et al. employed IBCs between
10th and 90th centiles and looked at a correlation across this
range. The different ways of analyzing the data thus complicate
direct comparisons between these studies (Harrington et al.,
1999; Godfrey et al., 1998). Importantly, studies from our
laboratory show that placental system A activity and BW:PW
ratio were negatively related although the correlation was not
statistically significant (P = 0.07, Figure 3C). Here again, this
trend toward significance was not seen when excluding those
pregnancies that had a BW:PW ratio outside the 10th and 90th
centiles (a total of 8 data points). Excluding these placentas
altered the P-value from 0.07 to 0.35, highlighting the significant
effect that these sub-groups had on the rest of the overall
correlation.
What is clear is that previous data represented here differs
from that expected from the UK MVM vesicle studies described
above (Godfrey et al., 1998; Harrington et al., 1999). This means
that the actual relationship between BW:PW ratio and system
A activity, particularly in non-pathological pregnancies, remains
unclear.
DISCUSSION
Data from the multiple studies described suggest that BW:PW
ratio, whilst fairly consistent across normal populations, is
altered in complications of pregnancy and particularly in
SGA/FGR. However, this should be tempered by the fact that
these differences are most obvious when examining multiple
gestational time points and that this effect lessens, but still
remains in a number of studies, at term. These data also reinforce
the importance of accurately measuring trimmed placental
weight in studies investigating placental function.
There are data suggesting that, in a non-pathological
population, placentas adapt system A transporter activity
according to placental and fetal size. These data are particularly
compelling in mouse models where placental nutrient transfer
capacity is positively related to F:P ratio, and thus placental
efficiency. Following analysis of system A data from our previous
studies (Ditchfield et al., 2010; Hayward et al., 2012; Lean et al.,
2014), we found little evidence of altered system A activity across
the normal placental weight range in women. Additionally, the
data suggesting a correlation between BW:PW ratio and systemA
appeared to be skewed by those pregnancies below the 10th, and
above the 90th, centile within the normal range. Thus, changes
in placental efficiency, as assumed by an altered BW:PW ratio,
were not matched by similar alterations in system A activity
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FIGURE 3 | Correlations of system A activity (pmol/mg protein) vs. trimmed placental weight (A), birthweight (B), and BW:PW ratio (C). Data is collated
from previously published studies within our laboratory (Ditchfield et al., 2010; Hayward et al., 2012; Lean et al., 2014). Dotted line denotes the 10th and 90th centile
of placental weight (A), birthweight (B) and BW:PW ratio (C), respectively. P < 0.05 indicates a significant correlation (Spearman correlation). N = 60, all subjects were
from an appropriate for gestational age (AGA) population, defined as >10th and <90th of individualized birthweight centiles.
as previously suggested (Harrington et al., 1999; Coan et al.,
2008a). Potential reasons for the disparity between the data
presented here and previous data in human (Godfrey et al.,
1998; Harrington et al., 1999) have been discussed in the earlier
section but may be reflective of the different techniques and the
types of analyses used (correlations vs. organization of data into
binned weight groups). In terms of disparities between human
and mouse data, and aside from species differences in placental
structure, studies in humans measure uptake of MeAIB into
the syncytiotrophoblast via sodium-dependent mechanisms. The
studies in mice measure unidirectional maternofetal clearance
of MeAIB per gram placenta. This calculation is based upon
fetal accumulation of MeAIB which must include a step whereby
MeAIB is transferred, by as yet undetermined mechanisms,
across the fetal facing basal plasma membrane of the trophoblast.
Additionally, the mouse studies will reflect both sodium-
dependent and –independent mechanisms of MeAIB transport.
These differences in what is being measured should thus be
considered when comparing across species.
An important point to make is that system A is only one
of a large number of nutrient transporter systems within the
placenta; further studies investigating other systems in detail
will be necessary to gain a more complete picture regarding
the presence or absence of placental adaptation, in terms of
nutrient transport, in normal and pathological populations.
These systems may include other amino acid transport systems
shown to be dysregulated in FGR such as system L (Jansson
et al., 1998)and TauT (Roos et al., 2007) but also other important
nutrients such as glucose and calcium whose placental transport
has yet to be extensively characterized across the normal
birthweight range in human pregnancy. Additionally, nutrient
sensing pathways such as the mechanistic target of rapamycin
(mTOR) pathway, important in matching placental amino acid
transport to maternal nutrient availability and downregulated in
FGR (Roos et al., 2007, 2009a,b), are worthy of investigation with
regards to placental adaptation.
With regards to the investigation of the extremes of BW:PW
ratio, an obvious but important point is that BW:PW ratio alone
only offers limited insight; it is crucial to determine whether it
is the placenta, or fetus, or both, that lie within the extremes
(<10th, >90th). This affords greater insight into the likelihood
of abnormal placental function in terms of nutrient transfer.
In terms of the ability of BW:PW ratio to detect those
pregnancies at risk of complications, particularly FGR, the
evidence suggests that low BW:PW ratio appears more predictive
of abnormal fetal growth in pre-term populations and that its
accuracy as a predictor at term may be diminished. However,
in order for interventions in pre-term populations, there is
a necessity for more accurate assessments of, in particular,
placental size in utero (Higgins et al., 2013).
BW:PW ratio has been mooted as a predictor of long-term
health (Barker et al., 1990) and, where morphological and
functional placental adaptation occurs, these adaptations will
affect the composition of the developing baby (Coan et al.,
2008a). It has been suggested that these adaptations in utero,
and the interplay between placental supply of nutrients and fetal
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nutrient demand, will ultimately play a role in an individual’s
ability to deal with physiological challenges throughout their life
(Sibley et al., 2010). Further studies dissecting the physiological
basis for alterations in BW:PW ratio will therefore be very
important in understanding the basis of in utero programming.
In conclusion, the concept of BW:PW ratio as a marker of
placental nutrient transfer efficiency is strongly supported by
studies in mice, with clear evidence of placentas adapting their
nutrient transfer capacity according to their size. In humans,
the data are less conclusive in an AGA population with respect
to the system A transporter and further studies are required
that investigate a range of nutrients and transport systems. This
knowledge would aid our understanding of whether placental
adaptation, in terms of nutrient transfer, occurs in humans,
and whether reduced placental nutrient transfer observed in
FGR/SGA is indeed as a result of failed adaptation.
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